Return
- 1M
- 3M
- 6M
- 1Y
- 3Y
- 5Y
This Fund:
Sensex:
BankFD:
Showing Funds Performance since Sep 07, 2020
Fund Overview
Min. investment
SIP ₹100 & Lump. ₹100
AUM (Fund size)
₹1,876 Cr
Lock In Period
N/A
Expense Ratio
2.11
Benchmark
BSE Healthcare
Exit Load
In respect of each purchase/switch-in of units, an Exit load of 1% is payable if units are redeemed /switched-out within 30 days from the date of allotment.No Exit Load is payable if units are redeemed / switchedout after 30 days from the date of allotment.
Summary
Latest details for HDFC Pharma and Healthcare Fund Growth include a ₹17.348 NAV as of Feb 20,2026 and returns since inception of --%. Minimum investments start at SIP ₹100. The HDFC Pharma and Healthcare Fund Growth AUM is ₹1,876 Cr, with a lock-in of N/A years, expense ratio of 2.11%, and benchmark BSE Healthcare. Exit load is - In respect of each purchase/switch-in of units, an Exit load of 1% is payable if units are redeemed /switched-out within 30 days from the date of allotment.No Exit Load is payable if units are redeemed / switchedout after 30 days from the date of allotment.. In the growth review for 1M Month/Year, the fund recorded 0.00% returns, against a category average of 0.00% and a category best of 0.00%.
Calculate Returns
You would have got
Your Investment Amount
- 1
- 2
- 3
- 4
- 5
Growth Review
| Duration | Fund Return(%) | Category Average(%) | Category Best(%) |
|---|
Portfolio Analysis
- Equity:
- Debt:
- Others
As on: 2026-01-31
View allocation % by
About Fund
HDFC Pharma and Healthcare Fund Growth managed by HDFC Mutual Fund,is a Equity - Sector Fundscheme with Assets Under Management of ₹1,876 Crore. The fund benchmarks its performance against the BSE Healthcare while maintaining an expense ratio of 2.11. Under the expert guidance of Nikhil Mathur ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.
Peer Comparison
| Fund Name | Ratings | AUM | Expense Ratio |
|---|---|---|---|
| This FundWhiteOak Capital ESG Best-In-Class Strategy Fund Growth | 0 | 56.57 CR | 2.34 |
| This FundInvesco India Manufacturing Fund Growth | 0 | 658.25 CR | 2.34 |
| This FundHDFC Pharma and Healthcare Fund Growth | 0 | 1875.89 CR | 2.11 |
| This FundICICI Prudential PSU Equity Fund Growth | 0 | 1924.01 CR | 2.09 |
| This FundNippon India Taiwan Equity Fund Growth | 3 | 448.04 CR | 2.43 |
| Fund Name | 1Y | 3Y |
|---|---|---|
| This FundWhiteOak Capital ESG Best-In-Class Strategy Fund Growth | 6.9969 | 0 |
| This FundInvesco India Manufacturing Fund Growth | 13.2503 | 0 |
| This FundHDFC Pharma and Healthcare Fund Growth | 13.4208 | 0 |
| This FundICICI Prudential PSU Equity Fund Growth | 23.5487 | 118.393 |
| This FundNippon India Taiwan Equity Fund Growth | 75.3532 | 178.1599 |
FAQs
HDFC Pharma and Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.
The expense ratio of HDFC Pharma and Healthcare Fund Growth is 2.11. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.
HDFC Pharma and Healthcare Fund Growth’s fund performance is as follows:
- 1 Month : %
- 6 Months : %
- 1 Year : %
- 3 Years : %
You can invest in HDFC Pharma and Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.
The fund size (AUM) of HDFC Pharma and Healthcare Fund Growth is ₹1,876 crore. It changes based on market performance, inflows, and outflows.
You can track your investment in HDFC Pharma and Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
Min Inv Amount: ₹500